XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
OPERATING EXPENSES        
Research and development $ 1,196,094 $ 1,255,074 $ 3,479,463 $ 4,613,302
General and administrative 614,647 532,801 1,787,632 1,707,514
Total operating expenses 1,810,741 1,787,875 5,267,095 6,320,816
LOSS FROM OPERATIONS (1,810,741) (1,787,875) (5,267,095) (6,320,816)
OTHER INCOME (EXPENSE)        
Interest income 107,937   249,453  
Interest expense   (4,789) (938) (6,050)
Other (expense) income, net 107,937 (4,789) 248,515 (6,050)
LOSS BEFORE INCOME TAX PROVISION (1,702,804) (1,792,664) (5,018,580) (6,326,866)
NET LOSS $ (1,702,804) $ (1,792,664) $ (5,018,580) $ (6,326,866)
Net loss/Weighted average common shares        
Net loss per common share- basic $ (0.15) $ (0.16) $ (0.43) $ (0.55)
Net loss per common share- diluted $ (0.15) $ (0.16) $ (0.43) $ (0.55)
Weighted average common shares - basic 11,636,041 11,540,296 11,612,735 11,527,069
Weighted average common shares - diluted 11,636,041 11,540,296 11,612,735 11,527,069